Navigation Links
Gamida Cell and Cellerix Partner on Feasibility Study

in terms of product development and partnerships."

"Cellerix has a promising pipeline of cell therapeutics in advanced clinical trials. Existing data shows that Gamida Cell's expansion technologies are very effective in hematopoietic stem cells. Combining the technologies of our companies could lead to developing a new line of cell therapeutics. We are looking forward to seeing the results of this collaboration with an eye on further co-development and commercialization opportunities," said Eduardo Bravo, CEO at Cellerix.

About Cellerix, S.A.

Cellerix is a biopharmaceutical company with a pipeline of late clinical stage cell therapy products (phase II and III) targeting indications that represent a high unmet medical need.

The company has three products undergoing clinical trials: Ontaril(R) (Cx401) for the treatment of complex perianal fistulas, currently in Phase III, first medicine expected to reach the market in 2011, Cx501 a cell therapy product for treating epidermolysis bullosa (EB) currently in Phase II and Cx601 consists of a formulation based on donor cells (allogeneic origin) for treating complex perianal fistulas in Crohn's disease patients now in phase II. Ontaril(R), Cx501 and Cx601 have been designated orphan status by the European Medicines Agency (EMEA). Cellerix has a solid investor base, its ownership structure includes blue chips international VCs and corporate funds from two big pharma companies.

For more information: please visit

About Gamida Cell

Gamida Cell Ltd. is a world leader in stem cell expansion technologies and therapeutic products. The company is developing a pipeline of products in stem cell transplantation and in tissue regeneration to effectively treat debilitating and often fatal illnesses such as cancer, hematological and autoimmune diseases. Gamida Cell's

SOURCE Gamida Cell LTD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
10. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
11. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
Post Your Comments:
(Date:10/1/2015)...  xG Health Solutions, a leading healthcare management ... platform for communication and collaboration with healthcare organizations. ... health plans improve the quality and efficiency of ... products and educational resources. "Our ... we know the process of re-engineering care delivery ...
(Date:10/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Aegis Growth Conference, taking place October 7-9, 2015 in ... of Oramed, will present a corporate overview on October ... 2015 Aegis Growth Conference Date: Thursday, October ...
(Date:10/1/2015)... ... ... Hearth in Potsdam, NY. and a member of the Masonry Heater Association of North ... northern New York. The masonry heater fireplace is beautiful, simple, and it burns a fraction ... the home comfortable but when it is below zero, their needs to be one fire ...
(Date:9/30/2015)... /PRNewswire/ - Resverlogix Corp. (the "Corporation") (TSX:RVX) today announced that, ... September 30, 2015, each of the five nominees proposed as ... August 17, 2015 were elected as directors.  Proxy voting results ... Withheld , % For , % WithheldDonald J. McCaffrey , ... , 0.40% Peter Johann , 32,990,226 ...
Breaking Biology Technology:xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Oramed to Present at the Aegis Capital Growth Conference 2Oramed to Present at the Aegis Capital Growth Conference 3The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2Resverlogix Announces Voting Results 2
... growth company of diversified businesses, ... Transportation Accessories Group has acquired ... zinc plating services. Chem-Chrome is ... has been a longtime processor ...
... Software, worldwide leader in e-document ... Fax and VSI-FAX(R) product families, ... 3.0. This new solution allows ... more efficiently, effectively, and economically ...
... nanoscale device developed by a University of Wisconsin-Madison Engineering ... electrons in such devices as laptop computers and provide ... This device will allow researchers to study ... heat dissipation on single electron transport in transistors. ...
Cached Biology Technology:Cool Computers 2Cool Computers 3
(Date:9/10/2015)... , Sept. 10, 2015 Report ... New Study Reveals Selling Opportunities and Revenue Prospects ... the future of biologics, especially new drug classes? ... will stay ahead with exclusive market data and ... explore trends, developments, results, opportunities and sales predictions. ...
(Date:9/9/2015)... VANCOUVER, British Columbia , Sept. 9, 2015 ... achieved numerous organizational and solution-based milestones, furthering the ... the perils of online fraud. NuData ... key in enhancing the company,s growth cycle. The ... machine learning to determine good user behavior from ...
(Date:9/2/2015)... , Sept. 2, 2015 Security ... concern for enterprises, banks, government organizations, telecommunications, hospitals, ... numeric keypads were previously being used to prevent ... of two-factor authentication, wherein individuals could gain access ... different components, such as hardware devices and numeric ...
Breaking Biology News(10 mins):Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 2Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 3Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 4Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 5Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 6NuData Security Achieves Significant Milestones, Furthers Commitment to Providing Unparalleled Online Fraud Detection 2Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3
... in India has risen in response to a 20-fold drop ... article in the Nov. 15 issue of Clinical Infectious Diseases, ... country has encouraged people to seek HIV treatment because of ... more than 5 million HIV-infected people living in India have ...
... people with compromised immune systems may be feasible ... who demonstrated their approach could protect against pneumocystis ... immune cells that HIV destroys in humans. The ... researchers, working in collaboration with researchers from the ...
... Researchers from Johns Hopkins have discovered the presence of ... These ion channels act like electrical wires and permit ... become all cell types of the body, to conduct ... selectively block some of these channels in implanted cells, ...
Cached Biology News:HIV mortality in India drops with introduction of generic antiretroviral therapy 2New vaccine platform may fight infections with causes from influenza to bioterrorism 2New vaccine platform may fight infections with causes from influenza to bioterrorism 3Stem cells' electric abilities might help their safe clinical use 2